Tolvaptan, an orally active non-peptide arginine vasopressin V2 receptor antagonist, reduces ascites in rats with chronic liver injury
2007 ◽
Vol 25
(1)
◽
pp. 1-13
◽
1996 ◽
Vol 98
(12)
◽
pp. 2729-2738
◽
2000 ◽
Vol 16
(3)
◽
pp. 203-216
◽
2018 ◽
Vol 33
(suppl_1)
◽
pp. i64-i65